Danaher Corporation (VIE:DHRC)

Market Cap	137.57B
Revenue (ttm)	20.75B
Net Income (ttm)	3.00B
Shares Out	n/a
EPS (ttm)	4.16
PE Ratio	45.92
Forward PE	27.79
Dividend	1.10 (0.57%)
Ex-Dividend Date	Sep 26, 2025

Volume	n/a
Average Volume	2
Open	195.88
Previous Close	196.42
Day's Range	194.58 - 196.16
52-Week Range	153.52 - 247.05
Beta	n/a
RSI	56.58
Earnings Date	Jan 28, 2026

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man...

• Industry: Laboratory Analytical Instruments
• Founded: 1969
• Employees: 63,000
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: DHRC

Financial Performance

In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.

Financial numbers in USD